Effects of advanced glycation end products on osteoclasts at different stages of differentiation.
10.12122/j.issn.1673-4254.2020.04.20
- Author:
Xiaoqian DING
1
;
Yun HU
1
;
Dan LUO
1
;
Yu TANG
1
;
Caiyu LI
1
;
Leilei ZHENG
1
Author Information
1. Affiliated Stomatology Hospital, Chongqing Medical University, Chongqing 401145, China.
- Publication Type:Journal Article
- Keywords:
Raw264.7 macrophages;
advanced glycation end products;
differentiation;
osteoclast
- MeSH:
Animals;
Bone Resorption;
Cell Differentiation;
Mice;
Osteoclasts;
RANK Ligand;
RAW 264.7 Cells;
Receptor Activator of Nuclear Factor-kappa B
- From:
Journal of Southern Medical University
2020;40(4):573-579
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To explore the effect of advanced glycation end products (AGEs) on osteoclasts at different stages of differentiation.
METHODS:Raw264.7 cells cultured were induced for osteoclastogenesis using RANKL, and the stages of differentiation of the osteoclasts were determined with TRAP staining. The cells were then randomly divided into control group, early-stage AGEs intervention group and late-stage AGEs intervention group. The viability of the cells after AGEs treatment was assessed using CCK-8 method. The cells were examined after the induction for osteoclastogenesis using TRAP staining, and the expression levels of RANK, NFATC-1, TRAF-6, TRAP and CTSK mRNAs were tested with RT-PCR; the expressions of CTSK and RANK proteins were detected using Western boltting.
RESULTS:We defined the initial 3 days of induction as the early stage of differentiation and the time beyond 3 days as the late stage of differentiation of Raw264.7 cells. Intervention with AGEs at 100 mg/L produced no significant effects on the viability of the cells, but AGEs suppressed the cell proliferation at a concentration exceeding 100 mg/L. The number of osteolasts in the early- and late-stage intervention groups was greater than that in the control group, but the cell count differed significantly only between the early-stage intervention group and control group ( < 0.05). The gene expressions of RANK, NFATC-1, TRAF-6, TRAP and CTSK all increased after the application of AGEs in both the early and late stages of differentiation, but the changes were significant only in the early-stage intervention group ( < 0.05). The changes in CTSK and RANK protein expressions were consistent with their mRNA expressions.
CONCLUSIONS:AGEs can affect the differentiation of osteoclasts differently when applied at different stages, and intervention with AGEs at the early stage produces stronger effect to promote osteoclast differentiation than its application at a late stage.
